Cargando…

The Need for a Consensus Next-generation Sequencing Panel for Mature Lymphoid Malignancies

Supplemental Digital Content is available in the text

Detalles Bibliográficos
Autores principales:	Sujobert, Pierre, Le Bris, Yannick, de Leval, Laurence, Gros, Audrey, Merlio, Jean Philippe, Pastoret, Cedric, Huet, Sarah, Sarkozy, Clémentine, Davi, Frédéric, Callanan, Mary, Thieblemont, Catherine, Sibon, David, Asnafi, Vahid, Preudhomme, Claude, Gaulard, Philippe, Jardin, Fabrice, Salles, Gilles, Macintyre, Elizabeth
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2018
Materias:	Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6745936/ https://www.ncbi.nlm.nih.gov/pubmed/31723808 http://dx.doi.org/10.1097/HS9.0000000000000169

Ejemplares similares

What Does This Mutation Mean? The Tools and Pitfalls of Variant Interpretation in Lymphoid Malignancies
por: Guillermin, Yann, et al.
Publicado: (2018)

Positron emission tomography-computed tomography before autologous stem cell transplant in follicular lymphoma: coming too late?
por: Sarkozy, Clémentine, et al.
Publicado: (2022)

The EHA Research Roadmap: Malignant Lymphoid Diseases
por: Dreyling, Martin, et al.
Publicado: (2022)

Extranodal T- and NK-cell lymphomas
por: de Leval, Laurence, et al.
Publicado: (2022)

The prognostic value of clonal heterogeneity and quantitative assessment of plasma circulating clonal IG-VDJ sequences at diagnosis in patients with follicular lymphoma
por: Sarkozy, Clémentine, et al.
Publicado: (2017)

Adult T cell leukemia aggressivenness correlates with loss of both 5-hydroxymethylcytosine and TET2 expression
por: Marçais, Ambroise, et al.
Publicado: (2016)

Unclassifiable Isolated Monoclonal Lymphocytosis: Comprehensive Description of a Retrospective Cohort
por: Degaud, Michaël, et al.
Publicado: (2019)

Integrative diagnosis of primary cutaneous large B-cell lymphomas supports the relevance of cell of origin profiling
por: Gros, Audrey, et al.
Publicado: (2022)

P1079: VERY LONG-TERM FOLLOW-UP OF RITUXIMAB MAINTENANCE IN YOUNG PATIENTS WITH MANTLE CELL LYMPHOMA INCLUDED IN THE LYMA TRIAL, A LYSA STUDY.
por: Sarkozy, Clementine, et al.
Publicado: (2023)

EBV-associated NK and T-cell lymphoid neoplasms
por: Kimura, Hiroshi, et al.
Publicado: (2022)

Recurrent TET2 mutations in adult T cell leukemia
por: Marçais, Ambroise, et al.
Publicado: (2014)

KIR3DL2 may represent a novel therapeutic target in aggressive systemic peripheral T-cell lymphoma
por: Decroos, Amandine, et al.
Publicado: (2023)

Targeted High-throughput Sequencing for Hematological Malignancies: A GBMHM Survey of Practice and Cost Evaluation in France
por: Darlington, Meryl, et al.
Publicado: (2023)

TREC mediated oncogenesis in human immature T lymphoid malignancies preferentially involves ZFP36L2
por: Balducci, Estelle, et al.
Publicado: (2023)

Controversies in the Treatment of Peripheral T-cell Lymphoma
por: Bachy, Emmanuel, et al.
Publicado: (2020)

Radiotherapy for gastric mucosa-associated lymphoid tissue lymphoma
por: Quéro, Laurent, et al.
Publicado: (2021)

Cytokines, Genetic Lesions and Signaling Pathways in Anaplastic Large Cell Lymphomas
por: Merlio, Jean-Philippe, et al.
Publicado: (2021)

VEGF(121), is predictor for survival in activated B-cell-like diffuse large B-cell lymphoma and is related to an immune response gene signature conserved in cancers
por: Broséus, Julien, et al.
Publicado: (2017)

How to Obtain a High Quality ctDNA in Lymphoma Patients: Preanalytical Tips and Tricks
por: Bourbon, Estelle, et al.
Publicado: (2021)

ALK-negative anaplastic large cell lymphoma with DUSP22 rearrangement has distinctive disease characteristics with better progression-free survival: a LYSA study
por: Sibon, David, et al.
Publicado: (2022)

Innate Lymphoid Cells in Intestinal Homeostasis and Inflammatory Bowel Disease
por: Saez, Angela, et al.
Publicado: (2021)

Xenograft and cell culture models of Sézary syndrome reveal cell of origin diversity and subclonal heterogeneity
por: Poglio, Sandrine, et al.
Publicado: (2020)

Improvement of Standardization of Molecular Analyses in Hematology: The 10-year GBMHM French Experience
por: Alary, Anne Sophie, et al.
Publicado: (2021)

A transcriptomic continuum of differentiation arrest identifies myeloid interface acute leukemias with poor prognosis
por: Bond, Jonathan, et al.
Publicado: (2020)

Editorial: The Role of Innate Lymphoid Cells in Mucosal Immunity
por: Borger, Jessica G., et al.
Publicado: (2020)

Expert central review in lymphoma diagnosis. Is there a need?
por: Laurent, Camille, et al.
Publicado: (2017)

How molecular advances may improve the diagnosis and management of PTCL patients
por: Drieux, Fanny, et al.
Publicado: (2023)

ROQUIN/RC3H1 Alterations Are Not Found in Angioimmunoblastic T-Cell Lymphoma
por: Auguste, Tiphanie, et al.
Publicado: (2013)

Commentary on the WHO classification of tumors of lymphoid tissues (2008): aggressive B-cell lymphomas
por: Balague Ponz, Olga, et al.
Publicado: (2009)

Commentary on the WHO classification of tumors of lymphoid tissues (2008): indolent B cell lymphomas
por: Ott, German, et al.
Publicado: (2009)

Telomerase Activation in Hematological Malignancies
por: Ropio, Joana, et al.
Publicado: (2016)

Combining gene expression profiling and machine learning to diagnose B-cell non-Hodgkin lymphoma
por: Bobée, Victor, et al.
Publicado: (2020)

Central nervous system relapse in patients over 80 years with diffuse large B‐cell lymphoma: an analysis of two LYSA studies
por: Cabannes‐Hamy, Aurélie, et al.
Publicado: (2018)

Azacytidine and Venetoclax in Relapsed and Refractory Patients With Angioimmunoblastic T-cell Lymphoma
por: Laribi, Kamel, et al.
Publicado: (2022)

Identification of stromal proteins overexpressed in nodular sclerosis Hodgkin lymphoma
por: Kischel, Philippe, et al.
Publicado: (2011)

Editorial: Novel treatments for diffuse large B-cell lymphoma: The post-CART era
por: Mussetti, Alberto, et al.
Publicado: (2022)

P1166: BRIGATINIB IN PATIENTS WITH ALK-POSITIVE ANAPLASTIC LARGE CELL LYMPHOMA WHO HAVE FAILED BRENTUXIMAB VEDOTIN
por: Veleanu, Layla, et al.
Publicado: (2023)

Type II enteropathy-associated T-cell lymphoma features a unique genomic profile with highly recurrent SETD2 alterations
por: Roberti, Annalisa, et al.
Publicado: (2016)

RUNX1 as a recombinase cofactor
por: Cieslak, Agata, et al.
Publicado: (2015)

TP53 alterations in primary and secondary Sézary syndrome: A diagnostic tool for the assessment of malignancy in patients with erythroderma
por: Gros, Audrey, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_e60e7bodnh793nbbrkbtnp2o8l